Cited by 154Blood transfusion and managementTrauma, Hemostasis, Coagulopathy, ResuscitationMaternal and fetal healthcare

Four years' experience of a ROTEM ® ‐guided algorithm for treatment of coagulopathy in obstetric haemorrhage

McNamara, H., Kenyon, C., Smith, R., Mallaiah, S., Barclay, P.·2019·Anaesthesia

Abstract

We report four years of observational data from a large UK hospital and tertiary referral unit, following the introduction of a rotational thromboelastometry-guided algorithm for treatment of coagulopathy in major obstetric haemorrhage. Fibrinogen concentrate was used to treat acquired hypofibrinogenaemia as defined by a FibTEM A5 value of < 7 mm, or 7-12 mm with ongoing or high risk of haemorrhage. Of 32,647 deliveries over 4 years, 893 (2.7%) women had an estimated blood loss ≥ 1500 ml. Two-hundred and three (23%) of these had a FibTEM A5 ≤ 12 mm and 110 received fibrinogen concentrate. We compared clinical outcomes and blood product use with 52 patients who met the same criteria, over a 12-month pre-intervention period during which shock packs were used. In the algorithm group, there was a significant reduction in the number of units (p < 0.0001) and total volume (p = 0.0007) of blood products transfused, with a reduction in transfusion-associated circulatory overload (p = 0.002). Women with placental abruption exhibited more severe coagulopathy and required higher doses of fibrinogen concentrate than women who bled due to other causes. Analysis of rotational thromboelastometry results demonstrated that coagulopathy is not observed in all women who suffer obstetric haemorrhage and cannot be predicted solely by blood loss. Therefore, formulaic treatment with blood products is not justified. When coagulopathy does occur, it appears to be multifactorial and can be severe. Point-of-care testing allows early identification and individualised treatment of coagulopathy. This is supported by the improved outcomes reported.

Integrity signals

Registry

Crossref · 10.1111/anae.14628

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Compared to other causes of obstetrical hemorrhage, pregnant people with significant abruption experience greater decreases in platelets, require more platelet transfusions, and have more acquired hypofibrinogenemia.

    “Compared to other causes of obstetrical hemorrhage, pregnant people with significant abruption experience greater decreases in platelets, require more platelet transfusions, and have more acquired hypofibrinogenemia (95–97).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McNamara, H., Kenyon, C., Smith, R., Mallaiah, S., & Barclay, P.
Affiliations
  • Liverpool Womens NHS Foundation Trust (GB)
  • Mid Cheshire Hospitals NHS Foundation Trust (GB)
  • Chelsea and Westminster Hospital NHS Foundation Trust (GB)
Corresponding author
McNamara, H.
Venue
Anaesthesia
Publisher
Wiley
Published
2019-04-05
Volume
74
Issue
8
Pages
984-991
ISSN
  • 0003-2409 (ISSN-L)
  • 1365-2044
OpenAlex
W2932734781
Cited by
154
References
25
Citations by year
2026: 11 · 2025: 18 · 2024: 15 · 2023: 22 · 2022: 32 · 2021: 26 · 2020: 23 · 2019: 6 · 2013: 1
FWCI
13.05
Type
journal article
Language
en
Open access
closed
Locations
  • Anaesthesia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Biochemistry › Blood transfusion and management
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
Keywords
obstetric hemorrhage, coagulopathy, rotational thromboelastometry, fibrinogen concentrate, blood product transfusion, transfusion-associated circulatory overload, placental abruption, point-of-care coagulation testing, treatment algorithm
MeSH terms
Algorithms, Blood Coagulation Disorders, Female, Fibrinogen, Postpartum Hemorrhage, Humans, Pregnancy, Prospective Studies, Thrombelastography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review